Zavain Dar insider trades
Open-market stock purchases and sales by Zavain Dar, Director at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 7, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Jul 1, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 17, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Apr 1, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 2, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- RXRX Recursion Pharmaceuticals, Inc: 1 sale, last Oct 1, 2026